Pharsight

Biovail patents expiration

1. Diltiazem Hydrochloride patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5529791 BIOVAIL Extended release form of diltiazem
Jun, 2013

(10 years ago)

Drugs and Companies using DILTIAZEM HYDROCHLORIDE ingredient

Market Authorisation Date: 28 January, 2000

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

DILTIAZEM HYDROCHLORIDE family patents

Family Patents